A new trading day began on Tuesday, with Twist Bioscience Corp (NASDAQ: TWST) stock price down -0.55% from the previous day of trading, before settling in for the closing price of $39.90. TWST’s price has ranged from $30.32 to $60.90 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 42.89% over the past five years. Meanwhile, its annual earnings per share averaged 43.36%. With a float of $56.37 million, this company’s outstanding shares have now reached $59.58 million.
Let’s look at the performance matrix of the company that is accounted for 923 employees. In terms of profitability, gross margin is 44.59%, operating margin of -63.15%, and the pretax margin is -59.59%.
Twist Bioscience Corp (TWST) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Twist Bioscience Corp is 5.50%, while institutional ownership is 110.71%. The most recent insider transaction that took place on Apr 23 ’25, was worth 82,310. In this transaction President and COO of this company sold 2,058 shares at a rate of $39.99, taking the stock ownership to the 265,460 shares. Before that another transaction happened on Apr 23 ’25, when Company’s Officer proposed sale 2,058 for $40.00, making the entire transaction worth $82,311.
Twist Bioscience Corp (TWST) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 43.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.54% during the next five years compared to 1.70% growth over the previous five years of trading.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Here are Twist Bioscience Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -1.50 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Twist Bioscience Corp (NASDAQ: TWST) saw its 5-day average volume 0.85 million, a negative change from its year-to-date volume of 1.07 million. As of the previous 9 days, the stock’s Stochastic %D was 84.21%. Additionally, its Average True Range was 3.04.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 29.41%, which indicates a significant decrease from 78.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.89% in the past 14 days, which was higher than the 65.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.95, while its 200-day Moving Average is $45.03. Nevertheless, the first resistance level for the watch stands at $40.48 in the near term. At $41.28, the stock is likely to face the second major resistance level. The third major resistance level sits at $42.20. If the price goes on to break the first support level at $38.76, it is likely to go to the next support level at $37.84. Assuming the price breaks the second support level, the third support level stands at $37.04.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
With a market capitalization of 2.37 billion, the company has a total of 59,651K Shares Outstanding. Currently, annual sales are 312,970 K while annual income is -208,730 K. The company’s previous quarter sales were 88,710 K while its latest quarter income was -31,590 K.
